Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

NCT00165035 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1701

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Disease

Interventions

DEVICE: CoStar Paclitaxel Drug Eluting Coronary Stent System
DEVICE: TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent

Sponsor

Cordis US Corp.

Collaborators

[object Object]